熱門資訊> 正文
Theriva Biologics申请普通股发行
2024-09-11 05:19
- Theriva Biologics (NYSE:TOVX) filed preliminary prospectus for offering of up to about 2.2M shares of common stock, together with warrants to purchase up to 2.2M shares of common stock.
- SEC Filing
More on Theriva Biologics
- Seeking Alpha’s Quant Rating on Theriva Biologics
- Historical earnings data for Theriva Biologics
- Financial information for Theriva Biologics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。